FDA
-
-
-
-
-
-
-
Lixte Biotechnology and City of Hope to Initiate Phase 1b Clinical Trial of Lixte’s Lead Compound LB-100 to Treat Small Cell Lung Cancer
-
-
-
322,218 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

